Literature DB >> 30904768

The relationship between self-reported sensory impairments and psychosocial health in older adults: a 4-year follow-up study using the English Longitudinal Study of Ageing.

A Yu1, A E M Liljas2.   

Abstract

OBJECTIVES: To explore cross-sectional and longitudinal relationships between self-reported hearing and vision impairments and self-rated health, quality of life (QoL) and depressive symptoms at 4-year follow-up. STUDY
DESIGN: The study involved cross-sectional and longitudinal analyses with 4-year follow-up using data from the English Longitudinal Study of Ageing.
METHODS: Community-dwelling adults (n = 3931) aged ≥50 years from the English Longitudinal Study of Ageing participated in this study. Self-reported hearing and vision were defined as good or poor. Self-rated health was treated as a dichotomous variable (good and poor health). QoL was based on the 19-item Critical Appraisal Skills Programme and treated as a continuous variable (score 0-57). Depressive symptoms were assessed using the eight-item Center for Epidemiologic Studies Depression Scale (CES-D8) and defined as CES-D≥3. Relationships between sensory impairments and self-rated health and depressive symptoms were analysed using logistic regression. Linear regression was used to assess the relationships between sensory impairments and QoL.
RESULTS: In cross-sectional analyses, both self-reported hearing and vision impairment were positively associated with all outcomes assessed. In longitudinal analyses, self-reported poor hearing and vision were associated with increased risks of poor self-rated health (hearing: odds ratio [OR] 1.65, 95% confidence interval [CI] 1.32, 2.05; vision: OR 1.57, 95% CI 1.16, 2.12) and depressive symptoms (hearing: OR 1.35, 95% CI 1.07, 1.71; vision: OR 1.44, 95% CI 1.09, 1.90) after adjustment for sociodemographic and lifestyle factors, chronic illness, mobility limitations and cognition. Poor hearing and poor vision were not associated with reduced QoL after adjustment for covariates.
CONCLUSIONS: The findings stress the importance of identifying and addressing sensory impairments in older adults to improve their health and well-being.
Copyright © 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ageing; Depression; Hearing impairment; Quality of life; Self-rated health; Vision impairment

Mesh:

Year:  2019        PMID: 30904768     DOI: 10.1016/j.puhe.2019.01.018

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

1.  Subclinical Hearing Loss is Associated With Depressive Symptoms.

Authors:  Justin S Golub; Katharine K Brewster; Adam M Brickman; Adam J Ciarleglio; Ana H Kim; José A Luchsinger; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2020-01-21       Impact factor: 4.105

2.  Age-related hearing loss, depression and auditory amplification: a randomized clinical trial.

Authors:  Tatiana Marques; Filipa D Marques; António Miguéis
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-16       Impact factor: 2.503

Review 3.  Depression in elderly patients with hearing loss: current perspectives.

Authors:  Suzanne Cosh; Catherine Helmer; Cecile Delcourt; Tamara G Robins; Phillip J Tully
Journal:  Clin Interv Aging       Date:  2019-08-14       Impact factor: 4.458

4.  Sensory and motor correlates of frailty: dissociation between frailty phenotype and frailty index.

Authors:  Florian Beier; Martin Löffler; Frauke Nees; Lucrezia Hausner; Lutz Frölich; Herta Flor
Journal:  BMC Geriatr       Date:  2022-09-15       Impact factor: 4.070

5.  Self-reported visual difficulties in Europe and related factors: a European population-based cross-sectional survey.

Authors:  Nicolas Leveziel; Simon Marillet; Tasanee Braithwaite; Tunde Peto; Pierre Ingrand; Shahina Pardhan; Alain M Bron; Jost B Jonas; Serge Resnikoff; Julie-Anne Little; Rupert R A Bourne
Journal:  Acta Ophthalmol       Date:  2020-10-07       Impact factor: 3.761

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.